These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 15201550)
21. Urotensin II levels in patients with chronic kidney disease and kidney transplants. Hursitoglu M; Tukek T; Cikrikcioglu MA; Kara O; Kazancioglu R; Ozkan O; Cakirca M; Akdogan F; Gundogan E; Aydin S; Beycan I; Gursu M; Dogan S; Erek A Ups J Med Sci; 2012 Mar; 117(1):22-7. PubMed ID: 22098077 [TBL] [Abstract][Full Text] [Related]
22. Association between essential hypertension and three vasoactive peptides, urotensin II, endothelin and adrenomedullin. Zhu L; Sui L; Wu S; Wang L; Fu J; Wang X Clin Exp Hypertens; 2015; 37(7):604-8. PubMed ID: 26207882 [TBL] [Abstract][Full Text] [Related]
23. Expressions of irisin and urotensin II and their relationships with blood pressure in patients with preeclampsia. Zhang LJ; Xie Q; Tang CS; Zhang AH Clin Exp Hypertens; 2017; 39(5):460-467. PubMed ID: 28534711 [TBL] [Abstract][Full Text] [Related]
25. Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure. Dschietzig T; Bartsch C; Pregla R; Zurbrügg HR; Armbruster FP; Richter C; Laule M; Romeyke E; Neubert C; Voelter W; Baumann G; Stangl K Regul Pept; 2002 Dec; 110(1):33-8. PubMed ID: 12468107 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic potential of blockade of the urotensin II system in systemic hypertension. Krum H; Kemp W Curr Hypertens Rep; 2007 Mar; 9(1):53-8. PubMed ID: 17362672 [TBL] [Abstract][Full Text] [Related]
27. Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension. Heller J; Schepke M; Neef M; Woitas R; Rabe C; Sauerbruch T J Hepatol; 2002 Dec; 37(6):767-72. PubMed ID: 12445417 [TBL] [Abstract][Full Text] [Related]
28. The differential extraction and immunoluminometric assay of Urotensin II and Urotensin-related peptide in heart failure. Jani PP; Narayan H; Ng LL Peptides; 2013 Feb; 40():72-6. PubMed ID: 23270674 [TBL] [Abstract][Full Text] [Related]
29. Skin vasodilator effect of exogenous urotensin-II in hypertensives not exposed to antihypertensive medication. Rossi M; Magagna A; Di Maria C; Franzoni F; Taddei S; Santoro G Blood Press; 2008; 17(1):18-25. PubMed ID: 18568688 [TBL] [Abstract][Full Text] [Related]
30. Urotensin-II: a novel systemic hypertensive factor in the cat. Behm DJ; Doe CP; Johns DG; Maniscalco K; Stankus GP; Wibberley A; Willette RN; Douglas SA Naunyn Schmiedebergs Arch Pharmacol; 2004 Mar; 369(3):274-80. PubMed ID: 14985938 [TBL] [Abstract][Full Text] [Related]
31. [The role of arginine-vasopressin and substance P in the pathogenesis of hypertension and their interrelation]. Cao SP; Zhao LY Zhonghua Nei Ke Za Zhi; 1993 May; 32(5):306-9. PubMed ID: 7505732 [TBL] [Abstract][Full Text] [Related]
32. Increased plasma levels of Urotensin-II in preeclampsia-eclampsia: a new mediator in pathogenesis? Balat O; Aksoy F; Kutlar I; Ugur MG; Iyikosker H; Balat A; Anarat R Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):33-8. PubMed ID: 15866083 [TBL] [Abstract][Full Text] [Related]
33. High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man. Wilkinson IB; Affolter JT; de Haas SL; Pellegrini MP; Boyd J; Winter MJ; Balment RJ; Webb DJ Cardiovasc Res; 2002 Feb; 53(2):341-7. PubMed ID: 11827684 [TBL] [Abstract][Full Text] [Related]
34. High remaining risk in poorly treated hypertension: the 'rule of halves' still exists. Weinehall L; Ohgren B; Persson M; Stegmayr B; Boman K; Hallmans G; Lindholm LH J Hypertens; 2002 Oct; 20(10):2081-8. PubMed ID: 12359988 [TBL] [Abstract][Full Text] [Related]
35. Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension. Kemp W; Krum H; Colman J; Bailey M; Yandle T; Richards M; Roberts S Liver Int; 2007 Nov; 27(9):1232-9. PubMed ID: 17919235 [TBL] [Abstract][Full Text] [Related]
36. Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance. Ong KL; Wong LY; Man YB; Leung RY; Song YQ; Lam KS; Cheung BM Peptides; 2006 Jul; 27(7):1659-67. PubMed ID: 16597476 [TBL] [Abstract][Full Text] [Related]
37. The role of the UTS2 gene polymorphisms and plasma Urotensin-II levels in breast cancer. Yumrutas O; Oztuzcu S; Büyükhatipoglu H; Bozgeyik I; Bozgeyik E; Igci YZ; Bagis H; Cevik MO; Kalender ME; Eslik Z; Arslan A Tumour Biol; 2015 Jun; 36(6):4427-32. PubMed ID: 25604143 [TBL] [Abstract][Full Text] [Related]
38. PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION AMONG TYPE 2 DIABETIC PATIENTS AT MOI TEACHING AND REFERRAL HOSPITAL, ELDORET, KENYA. Ndege BW; Diero LO; Owiti MO; Anjichi G; Siika AM East Afr Med J; 2014 Aug; 91(8):253-60. PubMed ID: 26862649 [TBL] [Abstract][Full Text] [Related]
39. [Plasma urotensin II level in patients with chronic congestive heart failure]. Jołda-Mydłowska B; Salomon P; Mazurek W Pol Arch Med Wewn; 2006 Dec; 116(6):1125-36. PubMed ID: 18634521 [TBL] [Abstract][Full Text] [Related]
40. Plasma urotensin-2 level and Thr21Met but not Ser89Asn polymorphisms of the urotensin-2 gene are associated with migraines. Geyik S; Ergun S; Kuzudişli S; Şensoy F; Temiz E; Altunışık E; Korkmaz M; Dağlı H; Kul S; Akçalı A; Neyal AM J Headache Pain; 2016; 17():36. PubMed ID: 27090416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]